BioNTech SE

22UA.XETRA

Frankfurt Stock Exchange (XETRA)

Exchange

Frankfurt Stock Exchange (XETRA)

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

BioNTech is a German biotechnology company that develops medicines using a technology called mRNA, which teaches the body's cells to fight diseases. It became widely known for co-developing the COVID-19 vaccine with Pfizer, which was one of the first mRNA vaccines ever approved for widespread use. The company focuses on cancer treatments, infectious diseases, and other serious illnesses.

BioNTech earns money mainly through product sales and royalties from its COVID-19 vaccine partnership with Pfizer, though vaccine revenues have dropped sharply since the pandemic peak. The company is headquartered in Mainz, Germany, and operates globally, with a strong cash reserve built during the pandemic that funds its ongoing research pipeline. Its biggest growth opportunity is its cancer immunotherapy pipeline, but the main risk is that it has not yet successfully commercialized a second major product, making it heavily dependent on a single revenue source.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

no trend

Data not available

Profit after running costs

Operating Margin

N/A

no trend

Data not available

Return on the money invested

ROCE

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

no trend

Data not available

Profit growth

EPS YoY

N/A

no trend

Data not available

How steady the profit is

EPS Consistency

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

no trend

Data not available

Spare cash per sale

FCF Margin

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

no trend

Data not available

Covers its interest

Interest Cover

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/A

no trend

Data not available

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial